Laura Bogliolo

Effectiveness of an integrated hospital-community care pathway for fragility fractures’ secondary prevention: the PROMOTER-II study

Laura Bogliolo, Silvia Grignaschi, Catherine Klersy, Pietro Perotti et autres

As the global population ages, osteoporosis and fragility fractures (FF) are emerging health concerns worldwide. This study assesses the effectiveness of an integrated hospital-community pathway in improving prescription and adherence to anti-fracture treatment. Additionally, it analyzes the re-fracture rate and mortality at …

it (code pays fourni par la source)

Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators

Emma Diletta Stea, Mariateresa Pugliano, Roberta Gualtierotti, Monica Mazzucato et autres

Atypical Hemolytic Uremic Syndrome (aHUS) is a severe, systemic, rare disease (RD) that can occur in people of all ages, and is associated with high rates of morbidity and mortality. Because the management of patients with aHUS can be difficult, more effective …

it, pt, fr, ca (code pays fourni par la source)

The need for consistent epidemiological data on chronic pain in Italy and beyond

Franca Benini, Rossana Berardi, Laura Bogliolo, Fabio Borrometi et autres

it (code pays fourni par la source)

Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study

Laura Bogliolo, Emanuele Cereda, Catherine Klersy, Ludovico De Stefano et autres

Introduction Several studies and meta-analyses suggested the role of vitamin D 25OH in preventing severe forms of coronavirus disease 2019 (COVID-19). However, the evidence on the clinical benefits of vitamin D 25OH adequacy in patients hospitalized for COVID-19 remain conflicting and speculative. …

it (code pays fourni par la source)

Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis

Bernardo D’Onofrio, Michele di Lernia, Ludovico De Stefano, Serena Bugatti et autres

Bone mineral density (BMD) reduction and fragility fractures still represent a major source of morbidity in rheumatoid arthritis (RA) patients, despite adequate control of the disease. An increasing number of clinical and experimental evidence supports the role of autoantibodies, especially anti-citrullinated protein …

it (code pays fourni par la source)

Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs

Ludovico De Stefano, Silvia Balduzzi, Laura Bogliolo, Bernardo D’Onofrio et autres

OBJECTIVES: The safety of COVID-19 vaccination in rheumatic patients treated with biological (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs (DMARDs) remains poorly explored. METHODS: Reactogenicity, safety and disease flares following each of the two doses of the BNT162b2 mRNA vaccine was …

it (code pays fourni par la source)

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Serena Bugatti, Ludovico De Stefano, Silvia Balduzzi, Maria Immacolata Greco et autres

it (code pays fourni par la source)

Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study

Riccardo Caccialanza, Elena Formisano, Catherine Klersy, Virginia Valeria Ferretti et autres

it (code pays fourni par la source)

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target

Serena Bugatti, Laura Bogliolo, Antonio Manzo, Ludovico De Stefano et autres

Objectives To investigate the association of anti-citrullinated protein antibodies (ACPA) with changes in systemic bone mineral density (BMD) in patients with early rheumatoid arthritis (RA) after two years of treat-to-target. Methods BMD was measured at the lumbar spine (LS) and femoral neck …

it (code pays fourni par la source)

Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’

Serena Bugatti, Silvia Balduzzi, Ludovico De Stefano, Antonio Manzo et autres

it (code pays fourni par la source)

Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman

Emiliano Marasco, Marco Mussa, Francesca Motta, Francesca Bobbio‐Pallavicini et autres

The prevalence of osteoporosis is about three times greater in people living with HIV than in the general population. Bisphosphonates are the only class of antiresorptive drugs which have proved to be safe and effective in HIV patients. However, bisphosphonates are not …

it, us (code pays fourni par la source)

Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics

Alessandro Biglia, Sara Monti, Valentina Morandi, Paolo Delvino et autres

"Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics." Scandinavian Journal of Rheumatology, 51(1), pp. 76–77

it (code pays fourni par la source)